CAS 152923-56-3

Daclizumab

CAS: 152923-56-3

Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.

Reinheit: SDS-PAGE:95% SEC-HPLC:99.99%

Farbe und Form: Transparent Liquid

Molekulargewicht: 144.12 kDa (Predicted)

Ref: TM-T73689

Dacliximab

CAS: 152923-56-3

Reinheit: 95%

Molekulargewicht: G/Mol

Ref: IN-DA00ACL6

Daclizumab

CAS: 152923-56-3

Anti-Human CD25 Monoclonal Antibody

Ref: 3D-CLA1061